Rett Syndrome -- an update

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Rett syndrome is a severe neurodevelopmental disorder primarily affecting females, characterized by loss of acquired skills, motor deficits, and cognitive impairment.
• It is predominantly caused by mutations in the methyl-CpG-binding protein 2 (MeCP2) gene located on the X chromosome.
• The precise molecular mechanisms underlying brain maturation defects in Rett syndrome are not fully understood.

Purpose of the Study:

• To summarize the clinical presentation, genetic basis, and neuropathological findings of Rett syndrome.
• To highlight the current understanding of the molecular pathogenesis and diagnostic approaches.
• To outline existing therapeutic strategies for managing Rett syndrome.

Main Methods:

• Review of clinical, genetic, neuropathological, and neurometabolic studies on Rett syndrome.
• Analysis of the role of MeCP2 gene mutations in neurodevelopment.
• Synthesis of information on diagnostic criteria and treatment options.

Main Results:

• Rett syndrome presents with a distinct pattern of regression, including loss of speech and hand skills, ataxia, and breathing irregularities.
• Neuropathological findings indicate reduced brain growth, neuronal size reduction, and synaptic development deficits.
• Neurometabolic alterations involve decreased levels of neurotransmitters like dopamine and serotonin, and other crucial neurochemicals.

Conclusions:

• Rett syndrome is a complex disorder resulting from MeCP2 gene mutations, leading to significant neurodevelopmental deficits.
• Understanding the molecular pathogenesis is crucial for developing targeted therapies.
• Current management focuses on symptomatic relief, anticonvulsants, and physiotherapy.